Efficacy of piperacillin-tazobactam in the treatment of surgical wound infection after clean-contaminated head and neck oncologic surgery

Head and Neck

Volumn 26, Issue 9, 2004, Pages 823-828

  Rodrigo, Juan P ^a   Sǔrez, Carlos ^a   Bernaldez, Ricardo ^b   Collado, Diego ^c   Morera, Eduardo ^b   García, Marta ^b   Alfonso, Carolina ^b   Del Palacio, Antonio ^b   Perolada, José M ^c   Zulueta, Agustín ^d   Casamitjana, José M ^e   Quesada, Juan L ^f   Gutiérrez, Raimundo ^g   González, Amparo ^h   Petreñas, Eduardo ⁱ   Martínez, Ramón ^j   Díaz, Francisco J ^k   Zapater, Enrique ^l  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

ⁱ HOSPITAL DE CRUCES   (Spain)

^j HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^k HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^l HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

more..

Author keywords

Clean contaminated; Efficacy; Piperacillin tazobactam; Surgery, oncology; Wound infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOXITIN; CLINDAMYCIN; GENTAMICIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; DIARRHEA; DRUG CHOICE; DRUG HYPERSENSITIVITY; EAR NOSE THROAT SURGERY; FEMALE; GLOSSECTOMY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; HYPOPHARYNX CANCER; INFECTION; INFECTION RATE; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTICENTER STUDY; NASOPHARYNX CANCER; OROPHARYNX CANCER; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SKIN ALLERGY; TREATMENT OUTCOME; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 4344714752     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20027     Document Type: Article

References (26)

1. Rodrigo Tapia JP, Alvarez Mendez JC, Suarez Nieto C, Gomez Martinez J, Fernandez Martinez JA, Martinez Sanchez JA. Bacteriología de las infecciones de la herida quirúrgica en cirugía oncológica de cabeza y cuello. Acta Otorrinolaringol Esp 1997;48:389-391.
2. Rodrigo Tapia JP, Alvarez Mendez JC, Gomez Martinez JR, Suarez Nieto C. Factores de riesgo en la infección de la herida quirúrgica en cirugía oncológica de cabeza y cuello. Acta Otorrinolaringol Esp 1998;49:221-224.
3. Penel N, Lefebvre D, Fournier C, Sarini J, Kara A, Lefebvre JL. Risk factors for wound infection in head and neck cancer surgery: a prospective study. Head Neck 2001;23:447-455.
4. Johnson JT, Myers EN, Thearle PB, Sigler BA, Schramm VL Jr. Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope 1984;94:46-51.
5. Weber RS, Raad I, Frankenthaler R, et al. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverage. Arch Otolaryngol Head Neck Surg 1992;118:1159-1163.
6. Rodrigo JP, Alvarez JC, Gomez JR, Suarez C, Fernandez JA, Martinez JA. Comparison of three prophylactic antibiotic regimens in clean-contaminated head and neck surgery. Head Neck 1997;19:188-193.
7. Robbins KT, Favrot S, Hanna D, Cole R. Risk of wound infection in patients with head and neck cancer. Head Neck 1990;12:143-148.
8. Girod DA, McCulloch TM, Tsue TT, Weymuller EA Jr. Risk factors for complications in clean-contaminated head and neck surgical procedures. Head Neck 1995;17:7-13.
9. Rubin J, Johnson JT, Wagner RL, Yu VL. Bacteriologic analysis of wound infection following major head and neck surgery. Arch Otolaryngol Head Neck Surg 1988;114: 969-972.
10. Clayman GL, Raad II, Hankins PD, Weber RS. Bacteriologic profile of surgical infection after antibiotic prophylaxis. Head Neck 1993;15:526-531.
11. Bumpous JM, Johnson JT. The infected wound and its management. Otolaryngol Clin North Am 1995;28: 987-1001.
12. Nomura S, Hanaki H, Nagayama A. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections. J Chemother 1997;9:89-94.
13. Jones RN, Pfaller MA, Fuchs PC, Aldridge K, Allen SD, Gerlach EH. Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains. Diagn Microbiol Infect Dis 1989;12: 489-494.
14. Murray PR, Cantrell HF, Lankford RB. Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveillance Group. Diagn Microbiol Infect Dis 1994; 19:111-120.
15. Appelbaum PC. Comparative susceptibility profile of piperacillin/ tazobactam against anaerobic bacteria. J Antimicrob Chemother 1993;31(suppl A):29-38.
16. File TM Jr, Tan JS. Efficacy and safety of piperacillin/ tazobactam in skin and soft tissue infections. Eur J Surg Suppl 1994;573:51-55.
17. Tassler H, Cullmann W, Elhardt D. Therapy of soft tissue infections with piperacillin/tazobactam. J Antimicrob Chemother 1993;31(suppl A):105-112.
18. Gould IM, Ansari A, Harvey G, Douglas JG, Smith CC, Reid TM. Piperacillin/tazobactam in the treatment of serious acute soft tissue infection. Drugs Exp Clin Res 1991; 17:187-190.
19. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
20. Beam TR Jr, Gilbert DN, Kunin CM. General guidelines for the clinical evaluation of anti-infective drug products. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992;15(suppl 1): S5-S32.
21. García M, Rodríguez J. Escherichia coli resistentes a amoxicilina clavulánico en infecciones del tracto urinario. Rev Esp Quimioter 1996;9(suppl 4):192.
22. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 2000;19:112-117.
23. Betriu C, Campos E, Cabronero C, Rodriguez-Avial C, Picazo JJ. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents. Antimicrob Agents Chemother 1990;34:671-673.
24. Johnson BS. Principles and practice of antibiotic therapy. Infect Dis Clin North Am 1999;13:851-870.
25. Hill MK, Sanders CV. Principles of antimicrobial therapy for head and neck infections. Infect Dis Clin North Am 1988;2:57-83.
26. Torres García A, Rubio Terres C, Alvarez Bravo J. Análisis farmacoeconómico de minimización de costes de tratamiento de las infecciones intraabdominales con piperacilina-tazobactam en comparación con cefotaxima más metronidazol. Cirugía Española 1999;65:28-34.